• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Analysis of reactivation of hepatitis B virus in the treatment of B cell non-Hodgkin's lymphoma in Hokkaido.

作者信息

Tsutsumi Yutaka, Shigematsu Akio, Hashino Satoshi, Tanaka Junji, Chiba Kouji, Masauzi Nobuo, Kobayashi Hajime, Kurosawa Mitsutoshi, Iwasaki Hiroshi, Morioka Masanobu, Asaka Masahiro, Imamura Masahiro

出版信息

Ann Hematol. 2009 Apr;88(4):375-7. doi: 10.1007/s00277-008-0585-6. Epub 2008 Aug 23.

DOI:10.1007/s00277-008-0585-6
PMID:18726097
Abstract
摘要

相似文献

1
Analysis of reactivation of hepatitis B virus in the treatment of B cell non-Hodgkin's lymphoma in Hokkaido.北海道B细胞非霍奇金淋巴瘤治疗中乙肝病毒再激活的分析
Ann Hematol. 2009 Apr;88(4):375-7. doi: 10.1007/s00277-008-0585-6. Epub 2008 Aug 23.
2
[Reactivation of hepatitis B virus due to rituximab plus CHOP after preemptive lamivudine administration in a patient with diffuse large B-cell lymphoma].
Gan To Kagaku Ryoho. 2007 Sep;34(9):1509-12.
3
Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma.利妥昔单抗治疗低度皮肤B细胞淋巴瘤后迟发性致死性乙型肝炎病毒再激活。
Br J Dermatol. 2006 Nov;155(5):1053-6. doi: 10.1111/j.1365-2133.2006.07451.x.
4
Fatal reactivation of hepatitis B after chemotherapy for lymphoma.淋巴瘤化疗后乙肝病毒致命性再激活
BMJ. 2008 Jul 1;337:a423. doi: 10.1136/bmj.39490.680498.BE.
5
Late reactivation of resolved hepatitis B virus infection: an increasing complication post rituximab-based regimens treatment?已缓解的乙型肝炎病毒感染的晚期再激活：基于利妥昔单抗方案治疗后日益增加的并发症？
Am J Hematol. 2008 Aug;83(8):673-5. doi: 10.1002/ajh.21214.
6
HCV-positive status and hepatitis flares in patients with B-cell non-Hodgkin's lymphoma treated with rituximab-containing regimens.含利妥昔单抗方案治疗的 B 细胞非霍奇金淋巴瘤患者的 HCV 阳性状态和肝炎发作。
Dig Liver Dis. 2011 Feb;43(2):139-42. doi: 10.1016/j.dld.2010.05.010. Epub 2010 Jun 15.
7
Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis.乙肝表面抗原阴性/乙肝核心抗体阳性患者的乙肝病毒再激活风险及常规抗病毒预防的作用
J Clin Oncol. 2009 May 20;27(15):2570-1; author reply 2571-2. doi: 10.1200/JCO.2009.21.9352. Epub 2009 Apr 13.
8
Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma.用于B细胞非霍奇金淋巴瘤的单克隆抗体疗法。
N Engl J Med. 2008 Aug 7;359(6):613-26. doi: 10.1056/NEJMra0708875.
9
Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.一名非霍奇金淋巴瘤患者在接受化疗前乙肝表面抗原阴性且核心抗体阳性，出现致命性乙肝病毒再激活。
J Clin Gastroenterol. 2009 May-Jun;43(5):496-8. doi: 10.1097/MCG.0b013e3181945942.
10
Fulminant hepatitis B following rituximab therapy in a patient with Evans syndrome and large B-cell lymphoma.利妥昔单抗治疗埃文斯综合征和大B细胞淋巴瘤患者后发生的暴发性乙型肝炎。
Am J Hematol. 2006 Apr;81(4):302. doi: 10.1002/ajh.20540.

引用本文的文献

1
Liver failure from delayed hepatitis B reactivation in anti-HBc-positive patient following rituximab for B-cell lymphoma.利妥昔单抗治疗 B 细胞淋巴瘤后乙型肝炎核心抗体阳性患者发生乙型肝炎再激活致肝衰竭
BMJ Case Rep. 2021 Jul 9;14(7):e243526. doi: 10.1136/bcr-2021-243526.
2
Hepatitis B virus reactivation with a rituximab-containing regimen.含利妥昔单抗方案导致的乙型肝炎病毒再激活。
World J Hepatol. 2015 Sep 28;7(21):2344-51. doi: 10.4254/wjh.v7.i21.2344.
3
Treatment of rheumatic diseases and hepatitis B virus coinfection.风湿性疾病与乙型肝炎病毒合并感染的治疗。
Rheumatol Int. 2015 Mar;35(3):385-92. doi: 10.1007/s00296-014-3195-8. Epub 2014 Dec 31.
4
Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study.抗病毒预防策略对乙型肝炎病毒感染的非霍奇金淋巴瘤患者化疗相关乙型肝炎再激活的影响：一项回顾性队列研究
Indian J Hematol Blood Transfus. 2014 Jun;30(2):97-104. doi: 10.1007/s12288-012-0195-2. Epub 2012 Oct 30.
5
Hepatitis B virus reactivation with rituximab-containing regimen.含利妥昔单抗方案导致的乙型肝炎病毒再激活。
World J Hepatol. 2013 Nov 27;5(11):612-20. doi: 10.4254/wjh.v5.i11.612.
6
An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study.一种预防接受预防性拉米夫定和化疗患者乙肝再激活的优化抗病毒修饰策略：一项试点研究。
Tumour Biol. 2013 Apr;34(2):909-18. doi: 10.1007/s13277-012-0626-6. Epub 2012 Dec 27.
7
Management of hepatitis B reactivation in patients receiving cancer chemotherapy.乙型肝炎病毒再激活患者在接受癌症化疗时的管理。
Therap Adv Gastroenterol. 2012 Sep;5(5):359-70. doi: 10.1177/1756283X12450245.
8
Management of rheumatic disease with comorbid HBV or HCV infection.合并 HBV 或 HCV 感染的风湿性疾病的管理。
Nat Rev Rheumatol. 2012 May 8;8(6):348-57. doi: 10.1038/nrrheum.2012.63.
9
Rituximab administration and reactivation of HBV.利妥昔单抗的使用与乙肝病毒再激活
Hepat Res Treat. 2010;2010:182067. doi: 10.1155/2010/182067. Epub 2010 Dec 1.
10
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports.利妥昔单抗相关的乙型肝炎病毒（HBV）再激活在淋巴增生性疾病中的作用：荟萃分析和 FDA 安全报告检查。
Ann Oncol. 2011 May;22(5):1170-1180. doi: 10.1093/annonc/mdq583. Epub 2010 Nov 29.